![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication May 10, 2007.
Revised August 1, 2007.
Accepted for publication August 1, 2007.
The effect of the endogenous cannabinoid anandamide on K+ currents activated by the KATP channel opener cromakalim was investigated in follicle-enclosed Xenopus oocytes using the two-electrode voltage-clamp technique. Anandamide (1-90 µM) reversibly inhibited cromakalim-induced K+ currents with an IC50 value of 8.1 ± 2 µM. Inhibition was noncompetitive and independent of membrane potential. Pretreatment of oocytes with the CB1 receptor antagonist SR141716A (1 µM), the CB2 receptor antagonist SR144528 (1 µM), or pertussis toxin (5 µg/ml) did not alter the inhibitory effect of anandamide, suggesting that known cannabinoid receptors are not involved in anandamide inhibition of K+ currents. Similarly, neither the amidohydrolase inhibitor, phenylmethylsulfonyl fluoride (0.2 mM) nor the cyclooxygenase inhibitor, indomethacin (5 µM) affected anandamide inhibition of K+ currents suggesting that the effects of anandamide are not mediated by its metabolic products. In radioligand binding studies, anandamide inhibited the specific binding of the KATP ligand [3H]glibenclamide in the oocyte microsomal fractions with an IC50 value of 6.3 ± 0.4 µM. Gonadotropin-induced oocyte maturation and the cromakalim-acceleration of progesterone-induced oocyte maturation were significantly inhibited in the presence of 10 µM anandamide. Collectively, these results indicate that cromakalim-activated K+ currents in follicular cells of Xenopus oocytes are modulated by anandamide via a cannabinoid receptor-independent mechanism and the inhibition of these channels by anandamide alters the responsiveness of oocytes to gonadotropin and progesterone.
Key words:
KATP channels, Xenopus oocytes, anandamide, cromakalim, electrophysiology, oocyte development